全文获取类型
收费全文 | 47745篇 |
免费 | 3464篇 |
国内免费 | 196篇 |
专业分类
耳鼻咽喉 | 567篇 |
儿科学 | 998篇 |
妇产科学 | 966篇 |
基础医学 | 6601篇 |
口腔科学 | 1004篇 |
临床医学 | 4758篇 |
内科学 | 10025篇 |
皮肤病学 | 1077篇 |
神经病学 | 4551篇 |
特种医学 | 1961篇 |
外国民族医学 | 2篇 |
外科学 | 8603篇 |
综合类 | 480篇 |
一般理论 | 76篇 |
预防医学 | 2673篇 |
眼科学 | 938篇 |
药学 | 2795篇 |
中国医学 | 75篇 |
肿瘤学 | 3255篇 |
出版年
2023年 | 468篇 |
2022年 | 920篇 |
2021年 | 1717篇 |
2020年 | 1020篇 |
2019年 | 1348篇 |
2018年 | 1527篇 |
2017年 | 1026篇 |
2016年 | 1199篇 |
2015年 | 1383篇 |
2014年 | 1871篇 |
2013年 | 2186篇 |
2012年 | 3562篇 |
2011年 | 3507篇 |
2010年 | 1949篇 |
2009年 | 1726篇 |
2008年 | 2729篇 |
2007年 | 2785篇 |
2006年 | 2589篇 |
2005年 | 2408篇 |
2004年 | 2226篇 |
2003年 | 2033篇 |
2002年 | 1863篇 |
2001年 | 535篇 |
2000年 | 520篇 |
1999年 | 541篇 |
1998年 | 430篇 |
1997年 | 339篇 |
1996年 | 254篇 |
1995年 | 247篇 |
1994年 | 208篇 |
1993年 | 212篇 |
1992年 | 365篇 |
1991年 | 337篇 |
1990年 | 308篇 |
1989年 | 270篇 |
1988年 | 258篇 |
1987年 | 242篇 |
1986年 | 234篇 |
1985年 | 261篇 |
1984年 | 216篇 |
1983年 | 204篇 |
1982年 | 168篇 |
1981年 | 158篇 |
1980年 | 168篇 |
1979年 | 182篇 |
1978年 | 150篇 |
1977年 | 136篇 |
1976年 | 135篇 |
1974年 | 142篇 |
1973年 | 121篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
Alexander Kulagin Igor Lisukov Maria Ivanova Irina Golubovskaya Irina Kruchkova Sergey Bondarenko Vladimir Vavilov Natalia Stancheva Elena Babenko Alexandra Sipol Natalia Pronkina Vladimir Kozlov Boris Afanasyev 《British journal of haematology》2014,164(4):546-554
Paroxysmal nocturnal haemoglobinuria (PNH) clones are frequently detected in patients with aplastic anaemia (AA). To evaluate the prognostic role of PNH clone presence we conducted a prospective study in 125 AA patients treated with combined immunosuppressive therapy (IST). Seventy‐four patients (59%) had a PNH clone (PNH+ patients) at diagnosis, with a median clone size of 0·60% in granulocytes and 0·15% in red blood cells. The response rate at 6 months was higher in PNH+ patients than that in PNH‐ patients, both after first‐ and second‐line IST: 68% vs. 45%, P = 0·0164 and 53% vs. 13%, P = 0·0502 respectively. Moreover, 42% of PNH+ patients achieved complete remission compared with only 16% of PNH‐ patients (P = 0·0029). In multivariate logistic regression analysis, PNH clone presence (odds ratio 2·56, P = 0·0180) and baseline absolute reticulocyte count (ARC) ≥30 × 109/l (odds ratio 5·19, P = 0·0011) were independent predictors of response to treatment. Stratification according to PNH positivity and ARC ≥30 × 109/l showed significant distinctions for cumulative incidence of response, overall and failure‐free survival. The results of this prospective study confirmed the favourable prognostic value of PNH clone presence in the setting of IST for AA. 相似文献
994.
Parkinson's disease is the second most common neurodegenerative disease worldwide, leading to a wide range of disability and medical complications. Managing patients with Parkinson's disease in the perioperative hospital setting can be particularly challenging. Suboptimal management can lead to medical complications, prolonged hospital stays, and delayed recovery. This review aims to address the most important issues related to caring for patients with Parkinson's disease perioperatively who are undergoing emergent or planned general surgery. It also intends to help hospitalists, internists, and other health care providers mitigate potential in-hospital morbidity and prevent prolonged recovery. Challenges in managing patients with Parkinson's disease in the perioperative hospital setting include disruption of medication schedules, “nothing by mouth” status, reduced mobility, and medication interactions and their side effects. Patients with Parkinson's disease are more prone to immobility and developing dysphagia, respiratory dysfunction, urinary retention, and psychiatric symptoms. These issues lead to higher rates of pneumonia, urinary tract infections, deconditioning, and falls compared with patients without Parkinson's disease, as well as prolonged hospital stays and a greater need for post-hospitalization rehabilitation. Steps can be taken to decrease these complications, including minimizing nothing by mouth status duration, using alternative routes of drugs administration when unable to give medications orally, avoiding drug interactions and medications that can worsen parkinsonism, assessing swallowing ability frequently, encouraging incentive spirometry, performing bladder scans, avoiding Foley catheters, and providing aggressive physical therapy. Knowing and anticipating these potential complications allow hospital physicians to mitigate nosocomial morbidity and shorten recovery times and hospital stays. 相似文献
995.
Jia Li James Cantley James G. Burchfield Christopher C. Meoli Jacqueline Stöckli P. Tess Whitworth Himani Pant Rima Chaudhuri Alexander J. A. Groffen Matthijs Verhage David E. James 《Diabetologia》2014,57(10):2173-2182
Aims/hypothesis
Glucose-stimulated insulin secretion (GSIS) and insulin-stimulated glucose uptake are processes that rely on regulated intracellular vesicle transport and vesicle fusion with the plasma membrane. DOC2A and DOC2B are calcium-sensitive proteins that were identified as key components of vesicle exocytosis in neurons. Our aim was to investigate the role of DOC2 isoforms in glucose homeostasis, insulin secretion and insulin action.Methods
DOC2 expression was measured by RT-PCR and western blotting. Body weight, glucose tolerance, insulin action and GSIS were assessed in wild-type (WT), Doc2a ?/? (Doc2aKO), Doc2b ?/? (Doc2bKO) and Doc2a ?/?/Doc2b ?/? (Doc2a/Doc2bKO) mice in vivo. In vitro GSIS and glucose uptake were assessed in isolated tissues, and exocytotic proteins measured by western blotting. GLUT4 translocation was assessed by epifluorescence microscopy.Results
Doc2b mRNA was detected in all tissues tested, whereas Doc2a was only detected in islets and the brain. Doc2aKO and Doc2bKO mice had minor glucose intolerance, while Doc2a/Doc2bKO mice showed pronounced glucose intolerance. GSIS was markedly impaired in Doc2a/Doc2bKO mice in vivo, and in isolated Doc2a/Doc2bKO islets in vitro. In contrast, Doc2bKO mice had only subtle defects in insulin secretion in vivo. Insulin action was impaired to a similar degree in both Doc2bKO and Doc2a/Doc2bKO mice. In vitro insulin-stimulated glucose transport and GLUT4 vesicle fusion were defective in adipocytes derived from Doc2bKO mice. Surprisingly, insulin action was not altered in muscle isolated from DOC2-null mice.Conclusions/interpretation
Our study identifies a critical role for DOC2B in insulin-stimulated glucose uptake in adipocytes, and for the synergistic regulation of GSIS by DOC2A and DOC2B in beta cells. 相似文献996.
Philipp Schuetz Natalie Friedli Eva Grolimund Alexander Kutz Sebastian Haubitz Mirjam Christ-Crain Robert Thomann Werner Zimmerli Claus Hoess Christoph Henzen Beat Mueller 《Diabetologia》2014,57(2):275-284
Aims/hypothesis
Despite the condition’s high prevalence, the influence of hyperglycaemia on clinical outcomes in non-critical-care inpatients with infections remains ill defined. In this study, we analysed associations of glucose levels at admission and during initial inpatient treatment with the inflammatory response and clinical outcome in community-acquired pneumonia (CAP) patients.Methods
This secondary observational analysis included 880 confirmed CAP patients. We used severity-adjusted multivariate regression models to investigate associations of initial and 96 h mean glucose levels with serially measured biomarker levels over 7 days (C-reactive protein [CRP], procalcitonin, white blood cell count [WBC], pro-adrenomedullin [ProADM]) and adverse clinical course (death and intensive-care unit admission).Results
In the 724 non-diabetic patients (82.3% of the study population), moderate or severe hyperglycaemia (glucose 6–11 mmol/l and >11 mmol/l, respectively) was associated with increased risk for adverse clinical course (adjusted OR [95% CI] 1.4 [0.8, 2.4] and 3.0 [1.1, 8.0], respectively) and with higher CRP, WBC and ProADM levels over 7 days (p?<?0.05, ANOVA, all days). In diabetic patients (n?=?156), no similar associations were found for initial hyperglycaemia, although mean 96 h glucose levels ?≥?9 mmol/l were associated with adverse clinical course (adjusted OR 5.4 [1.1, 25.8]; p?=?0.03). No effect modification by insulin treatment was detected (interaction terms p?>?0.2 for all analyses).Conclusions/interpretation
Initial hyperglycaemia in non-diabetic CAP patients, and prolonged hyperglycaemia in diabetic or non-diabetic CAP patients, are associated with a more pronounced inflammatory response and CAP-related adverse clinical outcome. Optimal glucose targets for insulin treatment of hyperglycaemia in non-critical-care settings should be defined. 相似文献997.
998.
Alexander Rodríguez-López Luisa N. Pimentel-Vera Angela J. Espejo-Mojica Annelies Van Hecke Petra Tiels Shunji Tomatsu Nico Callewaert Carlos J. Alméciga-Díaz 《Journal of pharmaceutical sciences》2019,108(8):2534-2541
Mucopolysaccharidosis IVA (MPS IVA or Morquio A syndrome) is a lysosomal storage disease caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), leading to lysosomal storage of keratan sulfate and chondroitin-6-sulfate. Currently, enzyme replacement therapy using an enzyme produced in CHO cells represents the main treatment option for MPS IVA patients. As an alternative, we reported the production of an active GALNS enzyme produced in the yeast Pichia pastoris (prGALNS), which showed internalization by cultured cells through a potential receptor-mediated process and similar post-translational processing as human enzyme. In this study, we further studied the therapeutic potential of prGALNS through the characterization of the N-glycosylation structure, in vitro cell uptake and keratan sulfate reduction, and in vivo biodistribution and generation of anti-prGALNS antibodies. Taken together, these results represent an important step in the development of a P. pastoris–based platform for production of a therapeutic GALNS for MPS IVA enzyme replacement therapy. 相似文献
999.
1000.
Maria Torner Adjmal Mangal Hubert Scharnagl Christian Jansen Michael Praktiknjo Alexander Queck Wenyi Gu Robert Schierwagen Jennifer Lehmann Frank E. Uschner Christiana Graf Christian P. Strassburg Javier Fernandez Tatjana Stojakovic Rainer Woitas Jonel Trebicka 《Liver international》2020,40(1):186-193